Ubs Group Ag Prime Medicine, Inc. Transaction History
Ubs Group Ag
- $582 Billion
- Q4 2025
A detailed history of Ubs Group Ag transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 2,440,583 shares of PRME stock, worth $8.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,440,583
Previous 304,773
700.79%
Holding current value
$8.22 Million
Previous $1.69 Million
387.2%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding PRME
# of Institutions
186Shares Held
92.4MCall Options Held
1.32MPut Options Held
931K-
Alphabet Inc. Mountain View, CA16.6MShares$55.8 Million5.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.22MShares$31.1 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.47MShares$21.8 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.48MShares$18.5 Million0.21% of portfolio
-
Black Rock Inc. New York, NY5.11MShares$17.2 Million0.0% of portfolio
About Prime Medicine, Inc.
- Ticker PRME
- Shares Outstandng 95,730,200
- Market Cap $323M